Article

FDA Brief

The FDA has approved what is said to be the first soft artificial cornea (AlphaCor, Argus Biomedical Pty. Ltd., Perth, Western Australia) for sale in the United States.

Related Videos
Related Content
New case study seeks to enhance perspectives in international ophthalmology partnerships
October 22nd 2024

New case study seeks to enhance perspectives in international ophthalmology partnerships

Week in Review - October 5, 2024
October 13th 2024

Week in Review - October 5, 2024

Inherited retinal diseases meet their therapeutic match
October 22nd 2024

Inherited retinal diseases meet their therapeutic match

EyePod: AI’s impact on managing ocular surface disease with Peter J. McDonnell, MD, and Laura M. Periman, MD
October 11th 2024

Innovation Series: AI’s impact on managing ocular surface disease with Peter J. McDonnell, MD, and Laura M. Periman, MD

Raising cataract surgery procedure to an art and an experience
October 21st 2024

Raising cataract surgery procedure to an art and an experience

AAO 2024: 3D printed eyeglasses bring vision care to children in underserved, remote communities
October 20th 2024

AAO 2024: 3D printed eyeglasses bring vision care to children in underserved, remote communities

© 2024 MJH Life Sciences

All rights reserved.